Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,409

It’s all in what you say and how you say it

FB Rice
-
Australia
-
May 22 2013

Often when an examiner rejects claims of a patent application during examination, our first reaction is to argue against the examiner's position. We

BRCA1 & BRCA2 genetic testing what do you get for $3000?

Phillips Ormonde Fitzpatrick
-
Australia
-
May 22 2013

With the recent media coverage of Angelina Jolie's decision to have a preventative double mastectomy following genetic testing for BRCA mutations and

Aventis Pharms., Inc. v. Amino Chems. Ltd.

Baker & Hostetler LLP
-
USA
-
May 21 2013

On May 20, 2013, in Aventis Pharms., Inc. v. Amino Chems. Ltd., the U.S. Court of Appeals for the Federal Circuit (Newman, Bryson, Reyna) reversed

Court upholds preliminary injunctions against generic sildenafil-based medicines

Danubia Patent & Law Office LLC
-
Hungary
-
May 20 2013

The Metropolitan Court of Budapest recently issued several decisions upholding preliminary injunctions against a group of generic pharmaceutical

UK: Court of Appeal refers questions on parallel imports to CJEU

Bird & Bird
-
European Union, United Kingdom
-
May 20 2013

The English Court of Appeal has considered the special derogation from the normal free movement of goods rules that formed part of the accession

Facing the patent cliff head-on

Baker Botts LLP
-
USA
-
May 17 2013

As the United States deals with the aftermath of the fiscal cliff, the pharmaceutical industry is facing a precipice of its own. As patents on

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

Bereskin & Parr LLP
-
Canada
-
May 16 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

What's in a name? Eli Lilly's olanzapine patent deemed valid on all grounds

Davies Collison Cave
-
Australia
-
May 16 2013

The Federal Court has upheld the validity of Eli Lilly’s Australian patent covering anti-psychotic drug olanzapine in a recent revocation action

A patent landscape analysis: iPSCs

Foley & Lardner LLP
-
USA
-
May 16 2013

There are several emerging technology clusters in the induced pluripotent stem cell (iPSC) space. Simon Elliot and I conducted a patent landscape

Advocate General confirms Dutch Court of Appeal's Cipralex decision

NLO (Nederlandsch Octrooibureau)
-
Netherlands
-
May 15 2013

Over the past few years Lundbeck's patents protecting its blockbuster drug Cipralex have been subject to invalidation actions around the world

next >

Search results

It’s all in what you say and how you say it

BRCA1 & BRCA2 genetic testing what do you get for $3000?

Aventis Pharms., Inc. v. Amino Chems. Ltd.

Court upholds preliminary injunctions against generic sildenafil-based medicines

UK: Court of Appeal refers questions on parallel imports to CJEU

Facing the patent cliff head-on

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

What's in a name? Eli Lilly's olanzapine patent deemed valid on all grounds

A patent landscape analysis: iPSCs

Advocate General confirms Dutch Court of Appeal's Cipralex decision

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea